A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00051142 |
Recruitment Status :
Completed
First Posted : January 7, 2003
Last Update Posted : August 5, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Glaucoma, Open-Angle Ocular Hypertension | Drug: Travoprost Drug: Latanoprost | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma or Ocular Hypertension |
Study Start Date : | February 2001 |
Actual Primary Completion Date : | June 2004 |
Actual Study Completion Date : | June 2004 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00051142
United States, Texas | |
Latin America | |
Fort Worth, Texas, United States |
Principal Investigator: | Alcon Investigators | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00051142 |
Other Study ID Numbers: |
C-01-36 |
First Posted: | January 7, 2003 Key Record Dates |
Last Update Posted: | August 5, 2008 |
Last Verified: | August 2008 |
Glaucoma POAG OAG OHT |
Glaucoma Glaucoma, Open-Angle Ocular Hypertension Hypertension Vascular Diseases |
Cardiovascular Diseases Eye Diseases Latanoprost Travoprost Antihypertensive Agents |